Fatigue Severity Scale: Difference between revisions
Kim Jackson (talk | contribs) m (Text replacement - " PD " to " Parkinson's ") |
Candace Goh (talk | contribs) No edit summary |
||
| (4 intermediate revisions by 2 users not shown) | |||
| Line 8: | Line 8: | ||
== Objective == | == Objective == | ||
The '''Fatigue Severity Scale''' is a 9-item scale which measures the severity of fatigue and its effect on a person's activities and lifestyle in patients with a variety of disorders. It was originally devised for people with [[Multiple Sclerosis]] or | The '''Fatigue Severity Scale (FSS)''' is a 9-item scale which measures the severity of fatigue and its effect on a person's activities and lifestyle in patients with a variety of disorders. It was originally devised for people with [[Multiple Sclerosis (MS)|Multiple Sclerosis]] (MS) or [[Systemic Lupus Erythematosus|systemic lupus erythematosus]]<ref>Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. Arch Neurol. 1989 Oct;46(10):1121-3. [https://www.researchgate.net/publication/20353316_The_Fatigue_Severity_Scale_Application_to_patients_with_multiple_sclerosis_and_systemic_lupus_erythematosus The Fatigue Severity Scale. Application to patients with multiple sclerosis and systemic lupus erythematosus]. Arch Neurol. 1989;46(10):1121-3. Accessed 27 June 2019. | ||
</ref>. | </ref>. | ||
{{#ev:youtube|https://www.youtube.com/watch?v=XAwDgczNCO0|width}}<ref>Mometrix Academy. Fatigue severity scale. Available from: https://www.youtube.com/watch?v=XAwDgczNCO0 )last accessed 3.3.2019)</ref> | {{#ev:youtube|https://www.youtube.com/watch?v=XAwDgczNCO0|width}}<ref>Mometrix Academy. Fatigue severity scale. Available from: https://www.youtube.com/watch?v=XAwDgczNCO0 )last accessed 3.3.2019)</ref> | ||
| Line 14: | Line 14: | ||
== Intended Population == | == Intended Population == | ||
Those with a variety of diagnoses including [[Rheumatoid Arthritis|arthritis]], [[Fibromyalgia|fibromyalgia]], [[ | Those with a variety of diagnoses including [[Rheumatoid Arthritis|arthritis]], [[Fibromyalgia|fibromyalgia]], [[Multiple Sclerosis (MS)|multiple sclerosis]], [[Parkinsons Disease|parkinson's disease]], [[stroke]] and [[COVID-19]]. | ||
== Method of Use == | == Method of Use == | ||
| Line 24: | Line 24: | ||
==== Test-retest Reliability ==== | ==== Test-retest Reliability ==== | ||
One study reported excellent test-retest reliability (ICC = 0.91) in a Brazilian-Portuguese version for people with Parkinson's (n = 30, mean age = 62 (11) years, mean time post- Parkinson's = 7.6 (6.5) years)<ref name="Valderramas et al">Valderramas, S., Feres, A. C., et al. "Reliability and validity study of a Brazilian-Portuguese version of the fatigue severity scale in Parkinson's patients." Arq Neuropsiquiatr 2012 70(7): 497-500</ref>. Similar results were found in a study of cirrhotic patients<ref name=":0" />. | |||
* One study reported excellent test-retest reliability (ICC = 0.91) in a Brazilian-Portuguese version for people with Parkinson's (n = 30, mean age = 62 (11) years, mean time post- Parkinson's = 7.6 (6.5) years)<ref name="Valderramas et al">Valderramas, S., Feres, A. C., et al. "Reliability and validity study of a Brazilian-Portuguese version of the fatigue severity scale in Parkinson's patients." Arq Neuropsiquiatr 2012 70(7): 497-500</ref>. Similar results were found in a study of cirrhotic patients<ref name=":0" />. | |||
* Another study reported that the test-retest reliability of FSS in strrj(ICC: 0.742, CI: 0.512-0.863, p < 0.001) was good. | |||
=== Validity === | === Validity === | ||
| Line 33: | Line 35: | ||
'''Parkinson’s Disease''' | '''Parkinson’s Disease''' | ||
*Excellent (r = -0.77) negative correlation with Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) scale<ref name="Hagell et al">Hagell, P., Hoglund, A., et al. "Measuring fatigue in Parkinson's: a psychometric study of two brief generic fatigue questionnaires." J Pain Symptom Manage 2006 32(5): 420-432</ref> | *Excellent (r = -0.77) negative correlation with Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) scale<ref name="Hagell et al">Hagell, P., Hoglund, A., et al. "Measuring fatigue in Parkinson's: a psychometric study of two brief generic fatigue questionnaires." J Pain Symptom Manage 2006 32(5): 420-432</ref> | ||
*Excellent (r = 0.62) correlation with Nottingham Health Profile (NHP-EN) scale<ref name="Hagell et al" /> | *Excellent (r = 0.62) correlation with Nottingham Health Profile (NHP-EN) scale<ref name="Hagell et al" /> | ||
*Excellent (r = 0.84) correlation with Parkinson’s Fatigue (PFS) scale <ref name="Grace et al">Grace, J., Mendelsohn, A., et al. "A comparison of fatigue measures in Parkinson's." Parkinsonism Relat Disord 2007 13(7): 443-445</ref> | *Excellent (r = 0.84) correlation with Parkinson’s Fatigue (PFS) scale <ref name="Grace et al">Grace, J., Mendelsohn, A., et al. "A comparison of fatigue measures in Parkinson's." Parkinsonism Relat Disord 2007 13(7): 443-445</ref> | ||
*Poor-adequate (r = 0.22-0.47) correlation with Parkinson’s Disease Questionnaire-39 (PDQ-39) scale; n = 66, mean age = 70.8 (9.9) years, time since Parkinson's = 70.2 (56.1) months) <ref name="Herlofson">Herlofson, K. and Larsen, J. P. "The influence of fatigue on health-related quality of life in patients with Parkinson's." Acta Neurol Scand 2003 107(1): 1-6</ref> | *Poor-adequate (r = 0.22-0.47) correlation with Parkinson’s Disease Questionnaire-39 (PDQ-39) scale; n = 66, mean age = 70.8 (9.9) years, time since Parkinson's = 70.2 (56.1) months) <ref name="Herlofson">Herlofson, K. and Larsen, J. P. "The influence of fatigue on health-related quality of life in patients with Parkinson's." Acta Neurol Scand 2003 107(1): 1-6</ref> | ||
| Line 44: | Line 46: | ||
=== Versions === | === Versions === | ||
[https://www.sralab.org/sites/default/files/2017-06/sleep-Fatigue-Severity-Scale.pdf English]<ref>Machado MO, Kang NY, Tai F, Sambhi RD, Berk M, Carvalho AF, Chada LP, Merola JF, Piguet V, Alavi A. Measuring fatigue: a meta‐review. International journal of dermatology. 2021 Sep;60(9):1053-69.</ref> | |||
Brazilian-Portuguese<ref name="Valderramas et al" /> | Brazilian-Portuguese<ref name="Valderramas et al" /> | ||
| Line 54: | Line 58: | ||
[[Category:Outcome_Measures]] | [[Category:Outcome_Measures]] | ||
[[Category:Parkinson' | [[Category:Parkinson's]] | ||
[[Category:Multiple Sclerosis]] [[Category:Multiple Sclerosis - Outcome Measures]] | [[Category:Multiple Sclerosis]] [[Category:Multiple Sclerosis - Outcome Measures]] | ||
[[Category:Stroke]] [[Category:Stroke - Outcome Measures]] | [[Category:Stroke]] [[Category:Stroke - Outcome Measures]] | ||
Latest revision as of 15:06, 31 March 2022
Original Editor - Sinead Greenan
Top Contributors - Sinead Greenan, Kim Jackson, Lauren Lopez, Laura Ritchie, Lucinda hampton, Evan Thomas, WikiSysop, Vidya Acharya, Candace Goh, Claire Knott and Wanda van Niekerk
Objective[edit | edit source]
The Fatigue Severity Scale (FSS) is a 9-item scale which measures the severity of fatigue and its effect on a person's activities and lifestyle in patients with a variety of disorders. It was originally devised for people with Multiple Sclerosis (MS) or systemic lupus erythematosus[1].
Intended Population[edit | edit source]
Those with a variety of diagnoses including arthritis, fibromyalgia, multiple sclerosis, parkinson's disease, stroke and COVID-19.
Method of Use[edit | edit source]
A self-report scale of nine items about fatigue, its severity and how it affects certain activities. Answers are scored on a seven point scale where 1 = strongly disagree and 7 = strongly agree. This means the minimum score possible is nine and the highest is 63. The higher the score, the more severe the fatigue is and the more it affects the person's activities. It is simple to understand and takes an average of eight minutes to answer[3].
Evidence[edit | edit source]
Reliability[edit | edit source]
Test-retest Reliability[edit | edit source]
- One study reported excellent test-retest reliability (ICC = 0.91) in a Brazilian-Portuguese version for people with Parkinson's (n = 30, mean age = 62 (11) years, mean time post- Parkinson's = 7.6 (6.5) years)[4]. Similar results were found in a study of cirrhotic patients[3].
- Another study reported that the test-retest reliability of FSS in strrj(ICC: 0.742, CI: 0.512-0.863, p < 0.001) was good.
Validity[edit | edit source]
Able to discriminate between groups (with and without fatigue) in a study of people with cirrhosis[3].
Correlates with depressive symptomology (Beck Depression Inventory) and quality of life (SF-36)[3].
Parkinson’s Disease
- Excellent (r = -0.77) negative correlation with Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) scale[5]
- Excellent (r = 0.62) correlation with Nottingham Health Profile (NHP-EN) scale[5]
- Excellent (r = 0.84) correlation with Parkinson’s Fatigue (PFS) scale [6]
- Poor-adequate (r = 0.22-0.47) correlation with Parkinson’s Disease Questionnaire-39 (PDQ-39) scale; n = 66, mean age = 70.8 (9.9) years, time since Parkinson's = 70.2 (56.1) months) [7]
Responsiveness[edit | edit source]
No significant changes observed with the scale pre and post liver transplant[3].
The FSS has been reported to have low floor and moderate ceiling effects[8].
Versions[edit | edit source]
Brazilian-Portuguese[4]
Finnish[10]
References[edit | edit source]
- ↑ Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. Arch Neurol. 1989 Oct;46(10):1121-3. The Fatigue Severity Scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol. 1989;46(10):1121-3. Accessed 27 June 2019.
- ↑ Mometrix Academy. Fatigue severity scale. Available from: https://www.youtube.com/watch?v=XAwDgczNCO0 )last accessed 3.3.2019)
- ↑ 3.0 3.1 3.2 3.3 3.4 Rossi D, Galant LH, Marroni CA. Psychometric property of fatigue severity scale and correlation with depression and quality of life in cirrhotics. Arq Gastroenterol. 2017. 54; 4: 344-348. Accessed 27 June 2019.
- ↑ 4.0 4.1 Valderramas, S., Feres, A. C., et al. "Reliability and validity study of a Brazilian-Portuguese version of the fatigue severity scale in Parkinson's patients." Arq Neuropsiquiatr 2012 70(7): 497-500
- ↑ 5.0 5.1 Hagell, P., Hoglund, A., et al. "Measuring fatigue in Parkinson's: a psychometric study of two brief generic fatigue questionnaires." J Pain Symptom Manage 2006 32(5): 420-432
- ↑ Grace, J., Mendelsohn, A., et al. "A comparison of fatigue measures in Parkinson's." Parkinsonism Relat Disord 2007 13(7): 443-445
- ↑ Herlofson, K. and Larsen, J. P. "The influence of fatigue on health-related quality of life in patients with Parkinson's." Acta Neurol Scand 2003 107(1): 1-6
- ↑ Amtmann D, Bamer AM, Noonan V, Lang N, Kim J, Cook KF. Comparison of the psychometric properties of two fatigue scales in multiple sclerosis. Rehabil Psychol. 2012. 57; 2: 159–166. Accessed 27 June 2019.
- ↑ Machado MO, Kang NY, Tai F, Sambhi RD, Berk M, Carvalho AF, Chada LP, Merola JF, Piguet V, Alavi A. Measuring fatigue: a meta‐review. International journal of dermatology. 2021 Sep;60(9):1053-69.
- ↑ Rosti‐Otajärvi E, Hämäläinen P, Wiksten A, Hakkarainen T, Ruutiainen J. Validity and reliability of the Fatigue Severity Scale in Finnish multiple sclerosis patients. Brain and Behaviour. 2017. Volume7; Issue7 : e00743. Accessed 27 June 2019.
